(lp0
S"Friday's Market Insights: Threshold Pharmaceuticals, Inc. , Innocoll ... Smarter Analyst - 22 hours ago Threshold Pharmaceuticals, Inc.  shares are rising 19% in Friday's trading session, after the drug maker announced that it has entered into a definitive agreement under which Molecular Templates will merge with a wholly owned subsidiary of&nbsp;...Threshold Pharma, Molecular Templates to Merge  - InvestopediaThreshold Pharma +64% on merger deal - Seeking Alpha"
p1
aS'Threshold Pharmaceuticals and Molecular Templates Agree to Combine GlobeNewswire  - Mar 17, 2017 SOUTH SAN FRANCISCO, Calif. and AUSTIN, Texas, March 17, 2017  -- Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, and Molecular Templates,&nbsp;...'
p2
aS"Threshold Pharmaceuticals' stock plunges after drug trial disappoints MarketWatch - Dec 7, 2015 Threshold Pharmaceuticals Inc.'s stock plunged in very active trade to a seven-year low Monday, after two late-stage trials of its investigational cancer treatment failed to meet their primary endpoints.Why Threshold Pharma Is Imploding - 24/7 Wall St.Merck KGaA Drops Cancer Drug Development After Studies Fail - Bloomberg"
p3
aS'Lookout for Price Target? Dynegy Inc. , Threshold Pharmaceuticals, Inc ... StockNewsJournal - Mar 14, 2017 Threshold Pharmaceuticals, Inc. , at its latest closing price of $0.66, it has a price-to-book ratio of 1.86, compared to an industry average at 9.98.Active Volume Stock Update: Threshold Pharmaceuticals Inc.  - HugoPressThreshold Pharmaceuticals, Inc.  added to 5 new portfolios - Post Analyst'
p4
aS"Threshold Pharma  Says Two Studies Didn't Meet Activity Thresholds ... StreetInsider.com - Sep 29, 2016 On September 29, 2016, the Compensation Committee of the Board of Directors  of Threshold Pharmaceuticals, Inc.  committed to implementing a workforce reduction constituting approximately&nbsp;...Is There Value In The Threshold Pharmaceuticals, Inc.  Sell Off? - Market Exclusive"
p5
aS'Analysts Weigh in on Two Collapsing Biotech Stocks: Threshold Pharmaceuticals ... Smarter Analyst - Sep 30, 2016 The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc.  and word from the FDA to place a drug program on full clinical hold for Alcobra Ltd (NASDAQ:ADHD ...'
p6
aS'Threshold Pharmaceuticals, Inc.  Might Just Have Become A Buyout ... Insider Financial - Oct 5, 2016 Threshold Pharmaceuticals, Inc.  collapsed last week on the announcement that its lead trial had missed its primary endpoint.'
p7
aS'Threshold Pharmaceuticals: Twice Bitten, Thrice Shy? Seeking Alpha - Nov 28, 2016 Threshold Pharmaceuticals Inc  is a biopharmaceutical company in operation since the mid 2000s, with projects in the tumor/cancer treatment environment.'
p8
aS'Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris ... PR Newswire  - Oct 25, 2016 IRVING, Texas and SOUTH SAN FRANCISCO, Calif., Oct. 25, 2016 /PRNewswire/ -- Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, and Threshold Pharmaceuticals, Inc. ,&nbsp;...'
p9
aS'Threshold Pharmaceuticals Inc  Making A Comeback Insider Financial - Mar 14, 2016 Shares of Threshold Pharmaceuticals Inc  fell off a cliff last December after its lead product candidate evofosfamide  failed two Phase 3 studies, MAESTRO and TH-CR-406/SARC021.'
p10
a.